Masaru Matsuda
See Remarks at Arcutis Biotherapeutics, Inc. (ARQT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 18SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 3,674112,508 held (−3%) | $25.00 | $92K | +6.3% |
| Sep 10SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 9,989116,182 held (−8%) | $25.03 | $250K | +6.2% |
| Aug 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 1,230126,171 held (−1%) | $26.12 | $32K | +1.8% |
| May 6SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 7,372127,573 held (−5%) | $23.27 | $172K | +14.2% |
| May 6SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 884126,689 held (−1%) | $23.61 | $21K | +12.6% |
| Mar 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 3,325143,678 held (−2%) | $27.95 | $93K | -4.9% |
| Mar 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 6,553137,125 held (−5%) | $25.16 | $165K | +5.6% |
| Mar 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 193136,932 held (−0%) | $25.91 | $5K | +2.6% |
| Mar 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 1,987136,932 held (−1%) | $25.70 | $51K | +3.4% |
| Feb 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 7,983142,658 held (−5%) | $25.50 | $204K | +4.2% |
| Feb 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 8,562134,096 held (−6%) | $24.97 | $214K | +6.4% |
| Feb 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 19,379114,717 held (−14%) | $25.24 | $489K | +5.3% |
| Feb 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 4,714110,003 held (−4%) | $25.63 | $121K | +3.7% |
| Dec 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 1,657150,641 held (−1%) | $30.23 | $50K | -12.1% |
| Nov 21SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 989153,037 held (−1%) | $27.95 | $28K | -4.9% |
| Nov 21SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 1,561151,476 held (−1%) | $28.50 | $44K | -6.7% |
| Nov 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 7,165154,069 held (−4%) | $24.71 | $177K | +7.6% |
| Nov 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 43154,026 held (−0%) | $25.40 | $1K | +4.6% |
- Sell
See Remarks Masaru Matsuda sold $92K of ARQT at $25.00 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Masaru Matsuda sold $250K of ARQT at $25.03 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Masaru Matsuda sold $32K of ARQT at $26.12 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Masaru Matsuda sold $172K of ARQT at $23.27 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Masaru Matsuda sold $21K of ARQT at $23.61 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Masaru Matsuda sold $93K of ARQT at $27.95 — pre-scheduled 10b5-1 plan sale.